Ovarian Cancer Pathogenesis: A Model in Evolution
Alison M. Karst(Gilead Sciences (United States)), Ronny Drapkin(University of Pennsylvania)
Cited by 294
Related Papers
Rethinking ovarian cancer: recommendations for improving outcomes
|Nature reviews. Cancer|2011|1.5k
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k
Prognostically relevant gene signatures of high-grade serous ovarian carcinoma
|Journal of Clinical Investigation|2012|591
A recurrent mutation in PALB2 in Finnish cancer families
|Nature|2007|461
Profiles of Genomic Instability in High-Grade Serous Ovarian Cancer Predict Treatment Outcome
|Clinical Cancer Research|2012|162